Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and preliminary efficacy of ipatasertib plus atezolizumab with paclitaxel or nab-paclitaxel in locally advanced or metastatic tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)
• ipatasertib (ipatasertib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-10-30